RxTROSPECT is a regulatory precedent identification tool that provides cloud-based analytics on US and EU oncology approvals (original approvals and follow-on indications). ➤ Who is RxTROSPECT for?Smaller biotechs and larger pharmaceutical teams who are planning oncology development strategies and/or looking to substantiate investor interest, for these individuals, having a clear picture of when and how approvals were granted is invaluable in these pivotal instances:• mapping out an optimal approval pathway, • raising or allocating funds, and• informing future discussions with the FDA on regulatory requirements➤ Why is RxTROSPECT valuable?Our users report saving tremendous amounts of time in precedent identification, enabling them to focus on assessment and strategy.➤ What does RxTROSPECT reveal?Rapidly identify precedent on indication, study design, pivotal study phase and size, regulatory pathways, key efficacy and safety data and so much more. ➤ How can I access RxTROSPECT?Visit rxtrospect.com or email us at theteam@rxtrospect.com to learn how our our RxTROSPECT users are leveraging our tech solution to expedite their development of regulatory strategy and drug development.